0.60
price up icon0.00%   0.00
after-market 시간 외 거래: .60
loading
전일 마감가:
$0.60
열려 있는:
$0.59
하루 거래량:
85,036
Relative Volume:
0.65
시가총액:
$55.26M
수익:
$775.30K
순이익/손실:
$-35.32M
주가수익비율:
-1.0714
EPS:
-0.56
순현금흐름:
$-19.15M
1주 성능:
+0.81%
1개월 성능:
-32.05%
6개월 성능:
-32.65%
1년 성능:
-25.84%
1일 변동 폭
Value
$0.5863
$0.65
1주일 범위
Value
$0.55
$0.65
52주 변동 폭
Value
$0.4301
$1.23

VolitionRX Ltd Stock (VNRX) Company Profile

Name
명칭
VolitionRX Ltd
Name
전화
646 650 1351
Name
주소
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Name
직원
37
Name
트위터
@VolitionRx
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
VNRX's Discussions on Twitter

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-02-01 다운그레이드 The Benchmark Company Buy → Hold
2022-02-17 재개 Cantor Fitzgerald Overweight
2021-03-10 개시 Cantor Fitzgerald Overweight
2018-05-16 개시 Maxim Group Buy
2018-05-14 재확인 The Benchmark Company Buy
2016-09-07 재확인 Rodman & Renshaw Buy
2016-02-01 개시 Rodman & Renshaw Buy
모두보기

VolitionRX Ltd 주식(VNRX)의 최신 뉴스

pulisher
Nov 04, 2024

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - Defense World

Nov 04, 2024
pulisher
Oct 27, 2024

VolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.com - Defense World

Oct 27, 2024
pulisher
Oct 09, 2024

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - Quantisnow

Oct 09, 2024
pulisher
Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Volition Appoints Dr. Ethel Rubin as an Independent Director - Quantisnow

Sep 30, 2024
pulisher
Sep 27, 2024

VolitionRx announces executive employment updates - Investing.com India

Sep 27, 2024
pulisher
Sep 18, 2024

Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY

Sep 18, 2024
pulisher
Sep 18, 2024

Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times

Sep 18, 2024
pulisher
Sep 18, 2024

Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend

Sep 18, 2024
pulisher
Sep 18, 2024

Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week

Sep 18, 2024
pulisher
Sep 18, 2024

Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse

Sep 18, 2024
pulisher
Sep 17, 2024

Volato Facing Class-action WARN Act Lawsuit - Aviation International News

Sep 17, 2024
pulisher
Sep 17, 2024

VolitionRx offers oncology assets for licensing - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 16, 2024

Volition Announces Board of Directors - TechBuzz News

Sep 16, 2024
pulisher
Sep 14, 2024

CRYPTOPSY's New Shirts Are Very Serious - Metal Injection

Sep 14, 2024
pulisher
Sep 13, 2024

Terminated Volato Employees File Class Action Lawsuit - FLYING

Sep 13, 2024
pulisher
Sep 12, 2024

LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24

Sep 12, 2024
pulisher
Sep 11, 2024

Investing in VolitionRX Ltd (VNRX): What You Must Know - Knox Daily

Sep 11, 2024
pulisher
Sep 11, 2024

Volition Hosts KOL Roundtable on Sepsis - Yahoo Finance

Sep 11, 2024
pulisher
Sep 05, 2024

VolitionRX Ltd [VNRX] Records 200-Day SMA of $0.7821 - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

The Potential Rise in the Price of VolitionRX Ltd (VNRX) following insiders activity - Knox Daily

Sep 02, 2024
pulisher
Aug 29, 2024

VNRX: Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR (human cancer detection method) and Nu.Q NET for sepsis. $7.0 million fi - Yahoo Finance

Aug 29, 2024
pulisher
Aug 28, 2024

Understanding the Risks of Investing in VolitionRX Ltd (VNRX) - Knox Daily

Aug 28, 2024
pulisher
Aug 27, 2024

Comparing OncoCyte (NASDAQ:OCX) & VolitionRx (NYSE:VNRX) - Defense World

Aug 27, 2024
pulisher
Aug 24, 2024

VolitionRx (NYSEAMERICAN:VNRX) Stock Price Passes Above 50-Day Moving Average of $0.00 - Defense World

Aug 24, 2024
pulisher
Aug 22, 2024

VolitionRx Limited (NYSE:VNRX) Director Guy Archibald Innes Purchases 150,000 Shares - Defense World

Aug 22, 2024
pulisher
Aug 18, 2024

VolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlight - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

Benchmark Reiterates Hold Rating for VolitionRx (NYSE:VNRX) - Defense World

Aug 18, 2024
pulisher
Aug 17, 2024

VolitionRx Limited (AMEX:VNRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 17, 2024
pulisher
Aug 16, 2024

Earnings call: VolitionRx reports strong growth and optimistic outlook - Investing.com

Aug 16, 2024
pulisher
Aug 15, 2024

VolitionRX: Q2 Earnings Snapshot - San Antonio Express-News

Aug 15, 2024
pulisher
Aug 12, 2024

Market Highlights: VolitionRX Ltd (VNRX) Ends on a Low Note at 0.53 - The Dwinnex

Aug 12, 2024
pulisher
Aug 12, 2024

Form 424B5 VOLITIONRX LTD - StreetInsider.com

Aug 12, 2024
pulisher
Aug 12, 2024

SEC Form 424B5 filed by VolitionRX Limited - Quantisnow

Aug 12, 2024
pulisher
Aug 09, 2024

VolitionRx announces $7 million stock and warrant sale - Investing.com India

Aug 09, 2024
pulisher
Aug 08, 2024

VolitionRx (NYSEAMERICAN:VNRX) Share Price Passes Above 50 Day Moving Average of $0.00 - Defense World

Aug 08, 2024
pulisher
Aug 07, 2024

VNRX Stock Touches 52-Week Low at $0.55 Amid Market Challenges - Investing.com

Aug 07, 2024
pulisher
Jul 31, 2024

VolitionRx (NYSEAMERICAN:VNRX) Shares Pass Above Fifty Day Moving Average of $0.00 - Defense World

Jul 31, 2024
pulisher
Jul 28, 2024

Q1 2025 Adani Energy Solutions Ltd Earnings Call Transcript - Stockxpo

Jul 28, 2024
pulisher
Jul 16, 2024

VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Jul 16, 2024
pulisher
Jul 15, 2024

Head And Neck Cancer Diagnostics Market Growth Analysis With Investment Opportunities - EIN News

Jul 15, 2024
pulisher
Jul 13, 2024

Virax Biolabs Group (NASDAQ:VRAX) & VolitionRx (NYSE:VNRX) Head-To-Head Review - Defense World

Jul 13, 2024
pulisher
Jul 09, 2024

Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing - StockTitan

Jul 09, 2024
pulisher
Jul 03, 2024

Envela Corp shareholders elect board, ratify auditor By Investing.com - Investing.com India

Jul 03, 2024
pulisher
Jul 03, 2024

VolitionRx expands stock plan and authorized shares By Investing.com - Investing.com India

Jul 03, 2024
pulisher
Jun 29, 2024

StockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX) - Defense World

Jun 29, 2024
pulisher
Jun 27, 2024

VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts - Quantisnow

Jun 27, 2024
pulisher
Jun 27, 2024

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting - StockTitan

Jun 27, 2024
pulisher
Jun 25, 2024

Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation - Quantisnow

Jun 25, 2024

VolitionRX Ltd (VNRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
자본화:     |  볼륨(24시간):